Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 5592 · Childhood Genital Mutilation Prevention Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

18 U.S.C. § 116A Gender-related medical treatment furnished to minors. New section

+130 −0Shown
More for 18 U.S.C. § 116A
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Chapter 7 of title 18, United States Code, is amended by inserting after section 116 the following new section:116A. Gender-related medical treatment furnished to minors. (a) In general.— Subject to subsection (c), whoever, in a circumstance described in subsection (b), knowingly performs or attempts to perform a gender-related medical treatment on a minor, shall be fined under this title, imprisoned not more than 10 years, or both. (b) Circumstances described.— For the purposes of subsection (a), the circumstances described in this subsection are that— (1) the offender or victim traveled in interstate or foreign commerce, or traveled using a means, channel, facility, or instrumentality of interstate or foreign commerce, in furtherance of or in connection with the conduct described in subsection (a); (2) the offender used a means, channel, facility, or instrumentality of interstate or foreign commerce in furtherance of or in connection with the conduct described in subsection (a); (3) any payment of any kind was made, directly or indirectly, in furtherance of or in connection with the conduct described in subsection (a) using any means, channel, facility, or instrumentality of interstate or foreign commerce or in or affecting interstate or foreign commerce; (4) the offender transmitted in interstate or foreign commerce any communication relating to or in furtherance of the conduct described in subsection (a) using any means, channel, facility, or instrumentality of interstate or foreign commerce or in or affecting interstate or foreign commerce by any means or in manner, including by computer, mail, wire, or electromagnetic transmission; (5) any instrument, item, substance, or other object that has traveled in interstate or foreign commerce was used to perform the conduct described in subsection (a); (6) the conduct described in subsection (a) occurred within the special maritime and territorial jurisdiction of the United States, or any territory or possession of the United States; or (7) the conduct described in subsection (a) otherwise occurred in or affected interstate or foreign commerce. (c) Exceptions.— (1) In general.— An individual who provides gender-related medical treatment to a minor shall not be considered to have violated the prohibition in subsection (a) if such medical treatment is provided to such minor for purposes of treating— (A) a disorder of sex development, diagnosed by a physician after such physician has determined through genetic or biochemical testing that such minor does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action; (B) irresolvably ambiguous biological sex characteristics of such minor, including the presence of— (i) 46 XX chromosomes with virilization; (ii) 46 XY chromosomes with undervirilization; or (iii) both ovarian and testicular tissue; or (C) an infection, injury, disease, or disorder caused or exacerbated by gender-related medical treatment that was furnished to such minor. (2) Exception for minors.— A minor who seeks gender-related medical treatment, or on whom gender-related medical treatment was performed, shall not be considered to have violated the prohibition in subsection (a). (d) Definitions.— In this section: (1) Gender-related medical treatment.— The term gender-related medical treatment means— (A) with respect to a female individual, medical treatments provided for purposes of addressing the perception of such individual that the gender or sex of such individual is not female, including— (i) surgical procedures, including— (I) vaginectomy; (II) hysterectomy; (III) oophorectomy; (IV) reconstruction of the urethra; (V) metoidioplasty; (VI) phalloplasty; (VII) salpingo-oophorectomy; (VIII) scrotoplasty; (IX) implantation of erection or testicular protheses; (X) subcutaneous mastectomy; (XI) vocal cord surgery; (XII) pectoral implants; and (XIII) penile transplantation; (ii) exogenous doses of testosterone or other androgens; and (iii) puberty blockers, including— (I) GnRH agonists; and (II) synthetic drugs that suppress the production of estrogen and progesterone or delay or suppress pubertal development in female individuals; and (B) with respect to a male individual, medical treatments provided for purposes of addressing the perception of such individual that the gender or sex of such individual is not male, including— (i) surgical procedures, including— (I) penectomy; (II) orchiectomy; (III) vaginoplasty; (IV) clitoroplasty; (V) vulvoplasty; (VI) augmentation mammoplasty; (VII) facial feminization surgery; (VIII) vocal cord surgery; (IX) chondrolaryngoplasty; (X) gluteal augmentation; and (XI) uterine transplantation; (ii) exogenous doses of estrogen; and (iii) puberty blockers, including— (I) GnRH agonists; and (II) synthetic drugs that suppress the production of testosterone or delay or suppress pubertal development in male individuals. (2) Female.— The term female means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization. (3) Gender.— The term gender— (A) means— (i) males, females, or the natural differences between males and females, unless such term is otherwise specified or used alone, rather than with or as an adjective modifying other words; and (ii) a synonym for sex; and (B) does not mean gender identity, experienced gender, gender expression, or gender roles. (4) Male.— The term male means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization. (5) Minor.— The term minor means an individual under 18 years of age. (6) Sex.— The term sex means the biological determination as to whether an individual is male or female..

§ 116A(a)–(d)

§ 116A. [inserted: Gender-related medical treatment furnished to minors.]

(a) [inserted: In general.—] [inserted: Subject to subsection (c), whoever, in a circumstance described in subsection (b), knowingly performs or attempts to perform a gender-related medical treatment on a minor, shall be fined under this title, imprisoned not more than 10 years, or both.]

(b) [inserted: Circumstances described.—] [inserted: For the purposes of subsection (a), the circumstances described in this subsection are that—]

(1) [inserted: the offender or victim traveled in interstate or foreign commerce, or traveled using a means, channel, facility, or instrumentality of interstate or foreign commerce, in furtherance of or in connection with the conduct described in subsection (a);]

(2) [inserted: the offender used a means, channel, facility, or instrumentality of interstate or foreign commerce in furtherance of or in connection with the conduct described in subsection (a);]

(3) [inserted: any payment of any kind was made, directly or indirectly, in furtherance of or in connection with the conduct described in subsection (a) using any means, channel, facility, or instrumentality of interstate or foreign commerce or in or affecting interstate or foreign commerce;]

(4) [inserted: the offender transmitted in interstate or foreign commerce any communication relating to or in furtherance of the conduct described in subsection (a) using any means, channel, facility, or instrumentality of interstate or foreign commerce or in or affecting interstate or foreign commerce by any means or in manner, including by computer, mail, wire, or electromagnetic transmission;]

(5) [inserted: any instrument, item, substance, or other object that has traveled in interstate or foreign commerce was used to perform the conduct described in subsection (a);]

(6) [inserted: the conduct described in subsection (a) occurred within the special maritime and territorial jurisdiction of the United States, or any territory or possession of the United States; or]

(7) [inserted: the conduct described in subsection (a) otherwise occurred in or affected interstate or foreign commerce.]

(c) [inserted: Exceptions.—]

(1) [inserted: In general.—] [inserted: An individual who provides gender-related medical treatment to a minor shall not be considered to have violated the prohibition in subsection (a) if such medical treatment is provided to such minor for purposes of treating—]

(A) [inserted: a disorder of sex development, diagnosed by a physician after such physician has determined through genetic or biochemical testing that such minor does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action;]

(B) [inserted: irresolvably ambiguous biological sex characteristics of such minor, including the presence of—]

(i) [inserted: 46 XX chromosomes with virilization;]

(ii) [inserted: 46 XY chromosomes with undervirilization; or]

(iii) [inserted: both ovarian and testicular tissue; or]

(C) [inserted: an infection, injury, disease, or disorder caused or exacerbated by gender-related medical treatment that was furnished to such minor.]

(2) [inserted: Exception for minors.—] [inserted: A minor who seeks gender-related medical treatment, or on whom gender-related medical treatment was performed, shall not be considered to have violated the prohibition in subsection (a).]

(d) [inserted: Definitions.—] [inserted: In this section:]

(1) [inserted: Gender-related medical treatment.—] [inserted: The term “gender-related medical treatment” means—]

(A) [inserted: with respect to a female individual, medical treatments provided for purposes of addressing the perception of such individual that the gender or sex of such individual is not female, including—]

(i) [inserted: surgical procedures, including—]

(I) [inserted: vaginectomy;]

(II) [inserted: hysterectomy;]

(III) [inserted: oophorectomy;]

(IV) [inserted: reconstruction of the urethra;]

(V) [inserted: metoidioplasty;]

(VI) [inserted: phalloplasty;]

(VII) [inserted: salpingo-oophorectomy;]

(VIII) [inserted: scrotoplasty;]

(IX) [inserted: implantation of erection or testicular protheses;]

(X) [inserted: subcutaneous mastectomy;]

(XI) [inserted: vocal cord surgery;]

(XII) [inserted: pectoral implants; and]

(XIII) [inserted: penile transplantation;]

(ii) [inserted: exogenous doses of testosterone or other androgens; and]

(iii) [inserted: puberty blockers, including—]

(I) [inserted: GnRH agonists; and]

(II) [inserted: synthetic drugs that suppress the production of estrogen and progesterone or delay or suppress pubertal development in female individuals; and]

(B) [inserted: with respect to a male individual, medical treatments provided for purposes of addressing the perception of such individual that the gender or sex of such individual is not male, including—]

(i) [inserted: surgical procedures, including—]

(I) [inserted: penectomy;]

(II) [inserted: orchiectomy;]

(III) [inserted: vaginoplasty;]

(IV) [inserted: clitoroplasty;]

(V) [inserted: vulvoplasty;]

(VI) [inserted: augmentation mammoplasty;]

(VII) [inserted: facial feminization surgery;]

(VIII) [inserted: vocal cord surgery;]

(IX) [inserted: chondrolaryngoplasty;]

(X) [inserted: gluteal augmentation; and]

(XI) [inserted: uterine transplantation;]

(ii) [inserted: exogenous doses of estrogen; and]

(iii) [inserted: puberty blockers, including—]

(I) [inserted: GnRH agonists; and]

(II) [inserted: synthetic drugs that suppress the production of testosterone or delay or suppress pubertal development in male individuals.]

(2) [inserted: Female.—] [inserted: The term “female” means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization.]

(3) [inserted: Gender.—] [inserted: The term “gender”—]

(A) [inserted: means—]

(i) [inserted: males, females, or the natural differences between males and females, unless such term is otherwise specified or used alone, rather than with or as an adjective modifying other words; and]

(ii) [inserted: a synonym for sex; and]

(B) [inserted: does not mean gender identity, experienced gender, gender expression, or gender roles.]

(4) [inserted: Male.—] [inserted: The term “male” means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization.]

(5) [inserted: Minor.—] [inserted: The term “minor” means an individual under 18 years of age.]

(6) [inserted: Sex.—] [inserted: The term “sex” means the biological determination as to whether an individual is male or female.]

42 U.S.C. § 1395y Exclusions from coverage and medicare as secondary payer

+4 −2Shown
More for 42 U.S.C. § 1395y
Read § 1395yOnly this section
3 changes the bill asks for here, 3 carried out
  1. Carried out:

    in paragraph (24), by striking or at the end;

  2. Carried out:

    in paragraph (25), by striking the period at the end and inserting ; or; and

  3. Carried out:

    by inserting after paragraph (25) the following new paragraph:(26) beginning on the date that is 90 days after the date of the enactment of the Childhood Genital Mutilation Prevention Act, which constitute gender-related medical treatment for minors described in section 116A of chapter 7 of title 18, United States Code, and are not …

§ 1395y(a)–(b)

Start of § 1395y to (a)(22) unchanged ·

(23) which are the technical component of advanced diagnostic imaging services described in section 1395m(e)(1)(B) of this title for which payment is made under the fee schedule established under section 1395w–4(b) of this title and that are furnished by a supplier (as defined in section 1395x(d) of this title), if such supplier is not accredited by an accreditation organization designated by the Secretary under section 1395m(e)(2)(B) of this title;

(24) where such expenses are for renal dialysis services (as defined in subparagraph (B) of section 1395rr(b)(14) of this title) for which payment is made under such section unless such payment is made under such section to a provider of services or a renal dialysis facility for such services;[struck: or]

(25) not later than January 1, 2014, for which the payment is other than by electronic funds transfer (EFT) or an electronic remittance in a form as specified in ASC X12 835 Health Care Payment and Remittance Advice or subsequent standard[struck: .][inserted: ; or]

(26) [inserted: beginning on the date that is 90 days after the date of the enactment of the Childhood Genital Mutilation Prevention Act, which constitute gender-related medical treatment for minors described in section 116A of chapter 7 of title 18, United States Code, and are not provided for the purposes described in subsection (c)(1) of such section.]

Paragraph (7) shall not apply to Federally qualified health center services described in section 1395x(aa)(3)(B) of this title. In making a national coverage determination (as defined in paragraph (1)(B) of section 1395ff(f) of this title) the Secretary shall ensure consistent with subsection (l) that the public is afforded notice and opportunity to comment prior to implementation by the Secretary of the determination; meetings of advisory committees with respect to the determination are made on the record; in making the determination, the Secretary has considered applicable information (including clinical experience and medical, technical, and scientific evidence) with respect to the subject matter of the determination; and in the determination, provide a clear statement of the basis for the determination (including responses to comments received from the public), the assumptions underlying that basis, and make available to the public the data (other than proprietary data) considered in making the determination.

(b) Medicare as secondary payer

(1) Requirements of group health plans

Rest of § 1395y unchanged ·

42 U.S.C. § 1395cc Agreements with providers of services; enrollment processes

+6 −0Shown
More for 42 U.S.C. § 1395cc
Read § 1395ccOnly this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1866 of the Social Security Act (42 U.S.C. 1395cc) is amended by adding at the end the following new subsection:(l) Exclusion of providers furnishing gender-Related medical treatment for minors.— Beginning on the date that is 90 days after the date of the enactment of the Childhood Genital Mutilation Prevention Act, with respect to a provider of services or supplier that, on or after the …

§ 1395cc(k)–(l)

Start of § 1395cc to (k)(3)(B) unchanged ·

(C) Time frame Not later than October 1, 2012, the Secretary shall publish the measures selected under this paragraph that will be applicable with respect to fiscal year 2014.

(4) Public availability of data submitted The Secretary shall establish procedures for making data submitted under paragraph (4) available to the public. Such procedures shall ensure that a hospital described in section 1395ww(d)(1)(B)(v) of this title has the opportunity to review the data that is to be made public with respect to the hospital prior to such data being made public. The Secretary shall report quality measures of process, structure, outcome, patients’ perspective on care, efficiency, and costs of care that relate to services furnished in such hospitals on the Internet website of the Centers for Medicare & Medicaid Services.

(l) [inserted: Exclusion of providers furnishing gender-Related medical treatment for minors.—] [inserted: Beginning on the date that is 90 days after the date of the enactment of the Childhood Genital Mutilation Prevention Act, with respect to a provider of services or supplier that, on or after the date that is 90 days after such date of enactment, furnishes gender-related medical treatment for minors, as described in section 116A of chapter 7 of title 18, United States Code to any individual (other than such a treatment that is furnished for the purposes described in subsection (c)(1) of such section), regardless of whether such individual is entitled to benefits under part A or enrolled under part B—]

(1) [inserted: if such provider of services or supplier is enrolled in the program under this title, the Secretary shall terminate such enrollment; and]

(2) [inserted: the Secretary may not enroll such provider of services or supplier as a new provider of services or supplier in the program under this title.]

Step through the changes